CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,832,793
- in 7 filings, $10.2M under 10b5-1 plans
Net −$14,832,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | SUMME GREGORY L Director | Grant or award | +237 | $135.46 | $32K | 45,909 |
| 2026-10-15 | CHASE WILLIAM J Director | Grant or award | +153 | $135.46 | $21K | 43,131 |
| 2026-10-15 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −400 | $133.12 | $53K | 361,871 |
| 2026-10-15 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −1,000 | $134.38 | $134K | 360,871 |
| 2026-10-15 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −3,400 | $135.44 | $461K | 357,471 |
| 2026-10-15 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −7,052 | $136.83 | $965K | 350,419 |
| 2026-10-15 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −6,034 | $137.63 | $830K | 344,385 |
| 2026-10-15 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −2,114 | $138.79 | $293K | 342,271 |
| 2026-10-15 | MIZELL STEVEN Director | Grant or award | +148 | $135.46 | $20K | 42,978 |
| 2026-10-05 | Partridge Andrew John Chief Growth Officer | Sale | −7,873 | $146.39 | $1.2M | 155,865 |
| 2026-10-05 | Freidin Aaron Chief Financial Officer | Sale | −23,619 | $146.39 | $3.5M | 225,364 |
| 2026-09-21 | Freidin Aaron Chief Financial Officer | Sale 10b5-1 | −1,779 | $92.26 | $164K | 251,304 |
| 2026-09-21 | Freidin Aaron Chief Financial Officer | Sale 10b5-1 | −1,800 | $93.92 | $169K | 249,504 |
| 2026-09-21 | Freidin Aaron Chief Financial Officer | Sale 10b5-1 | −521 | $95.00 | $49K | 248,983 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Option exercise 10b5-1 | +26,452 | $14.00 | $370K | 423,723 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −2,125 | $92.32 | $196K | 421,598 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −1,454 | $93.61 | $136K | 420,144 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −37,752 | $94.98 | $3.6M | 382,392 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −6,200 | $96.43 | $598K | 376,192 |
| 2026-09-21 | Ofman Joshua J. Chief Executive Officer | Sale 10b5-1 | −1,400 | $97.84 | $137K | 374,792 |
Page 1 of 8 · 144 trades